Nevada seismologists say federal funding and a new implementation plan with the USGS could bring ShakeAlert statewide, giving residents seconds of warning before shaking arrives.

A global biotech convention has crowded downtown San Diego this week as thousands of researchers, investors and companies converge for panels, partner meetings and exhibits.

PSC secured a $10M NSF award to build Bridges-3, a next-gen supercomputer planned to go live in summer 2027 and designed to boost AI and large-data research in Pittsburgh.

A 55‑ton cyclotron rolled into University City this week, marking a milestone for Penn Medicine’s $224M Roberts Proton Therapy Center set to open in late 2027.

Sunrun, Tesla and startups are pitching a plan to marshal rooftop solar, batteries and smart devices in millions of homes to free power for AI data centers during peak demand. Regulators and local communities are watching closely.

A U.N. report finds data centers already consume country‑scale energy and could double water and power use by 2030; local officials in North Florida are taking notice.

Antares Therapeutics has struck a partnership with Novartis that could be worth about $1.9 billion, bringing fresh funding to its South San Francisco and Boston teams.

Duke researchers say a catheter‑delivered gene therapy restored pumping power and cut arrhythmias in lab‑grown heart tissue and monkeys, suggesting a possible one‑shot treatment for heart‑attack damage.

Oregon‑based Rapta has established a regional headquarters in Orlando to serve aerospace, defense and space manufacturers across the Eastern United States. The move ties the AI firm closer to the Space Coast and local industry partners.

University of Michigan neurosurgeons implanted Paradromics’ fully implantable Connexus BCI in a patient last week, launching the FDA-approved Connect‑One study and a six‑year follow‑up.

Northwestern's Project DRIVE provided software Apple used to let Vision Pro wearers steer powered wheelchairs with their eyes. The feature rolls out initially with limited drive‑system support.

CHLA and UCLA were awarded up to $17.25M to form IMPACT‑LA, a West Coast site in ARIA’s international autism trials network that aims to speed therapies and build inclusive datasets.

UCLA published a step‑by‑step protocol and open code for an AI‑assisted platform that tracks drug responses in thousands of bioprinted tumor organoids. The methods aim to speed functional testing and move personalized therapy screening closer to clinical use.